Day: October 15, 2024

Company establishes relationship with the United States Army Communications-Electronics Command SAN JUAN, Puerto Rico, Oct. 15, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today announced it secured a $1 million contract for its Edge 130 Blue drones from the United States Army Communications-Electronics Command (CECOM). The contract was secured through Noble, a leading provider of global sustainment and operations support for the U.S. Military and civilian government agencies, and was coordinated for procurement by the U.S. Defense Logistics Agency (DLA) on behalf of CECOM. FlightWave, an industry-leading provider of VTOL drone, sensor and software solutions was acquired by Red...

New High-Grade Zone Emerging East of Ghanie Main Zone. Ghanie Main deposit continues to grow along strike and is open to depth. OMZ Shear 3 southern extensions intercepted with multiple visible gold showings.TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased to provide an update on its ongoing exploration program at the Company’s 58,000-acre OKO-Aremu gold project, Guyana. G2 currently has five rigs operating at the project, building on the Company’s current mineral resource which is comprised of 922,000 ounces of gold (Indicated) and 1,099,000 ounces (Inferred) [see press release dated April 03, 2024]. G2 continues to expand and define existing gold zones whilst discovering new high grade parallel zones of gold mineralization. The Company intends to issue...

U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference in Early 2025 BRAINTREE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it has successfully completed enrollment and follow up for all patients in its ACCESS-PVI human clinical trial. The Company remains on track to file its 510(k) submission with the U.S. Food and Drug Administration (FDA) by of the end of 2024. The Company also announced that it is accelerating its go-to-market strategy. It expects to begin building out the commercial infrastructure, including the hiring of a seasoned healthcare executive to lead its sales efforts, upon the FDA clearance, which is expected during...

YOKNEAM ILLIT, ISRAEL, Oct. 15, 2024 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announces the collaboration with RayNeo™ (“RayNeo”), a leader in augmented reality (AR) technology, to collaborate in delivering mass production level solution of next-generation neural interface AR glasses. Both parties will be showcasing how neural interface technology can be seamlessly integrated into AR devices, enhancing user experience by enabling hands-free, gesture-based interactions in augmented and mixed reality environments. RayNeo is known for its innovations in AR, developing cutting-edge AR glasses that enhance immersive experiences by overlaying digital...

Tel Aviv, Oct. 15, 2024 (GLOBE NEWSWIRE) — ZOOZ POWER Ltd. (NASDAQ and TASE: ZOOZ), the leading provider of Flywheel-based power boosting and power management solutions enabling ultra-fast multi ports EV charging, today announced that Erez Zimerman, Chief Executive Officer, will present at the LD Micro Main Event XVII in Los Angeles, on Wednesday, October 30, 2024, at 8:30am PT / 11:30am ET. Representatives of ZOOZ Power’s management will be available on site for one-on-one meetings. To schedule a meeting, please contact LD Micro or Miri Segal at msegal@ms-ir.com. A webcast of the presentation will be streamed live at the following link: https://me24.sequireevents.com/. A replay of the webcast will be available approximately 24 hours after the presentation ends. About ZOOZ Power ZOOZ Power is the leading provider of Flywheel-based...

– GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024 – – RPDD Provides Eligibility for GPS to Receive a Priority Review Voucher (PRV) Upon Marketing Approval that can be Transferred/Sold to Other Parties – – Recent Valuations for PRVs Remain Attractive (~$100 million/each) – NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to Galinpepimut-S (GPS), an immunotherapeutic targeting Wilms Tumor-1 (WT1), for the treatment of pediatric...